))
Tyler O’Malley on Validation of CB-CAPs Distinguishing SLE from Fibromyalgia
Manage episode 353516539 series 3428257
Konten disediakan oleh Exagen Podcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Exagen Podcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
How can a multianalyte assay panel help distinguish SLE from fibromyalgia and chronic localized pain? And what impact does this have on rheumatologists working to help determine their patients’ conditions?
Join Exagen and Tyler O’Malley, Senior Director of Clinical Affairs for Exagen, as he breaks down the abstract, Multi-Center Validation of Cell-Bound Complement Activation Products a Multianalyte Assay Panel Distinguishing Systemic Lupus Erythematosus from Primary Fibromyalgia. Tyler dives into how the study came to be and its clinical importance to both providers and patients.
3 episode
Bagikan
